[Rifaximin in combined treatment of the Helicobacter pylori infection in childhood].

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 21560396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Effectiveness and Safety of Rifaximin-Containing Regimens for Helicobacter pylori Eradication: Systematic Review – Are They Potential Eradication Regimens?

  2022cites this paper
• Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Helicobacter pylori Eradication

  2020cites this paper
• Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibiotics

  2019cites this paper
• Five alternative Helicobacter pylori antibiotics to counter high levofloxacin and metronidazole resistance in the Dominican Republic

  2019cites this paper
• Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection

  2018cites this paper
• Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.

  2017influential citation